Immunovant, Inc. (IMVT)

NASDAQ:IMVT

IMVT

Immunovant

RESEARCH TOOLSreports

Want to see IMVT full AI Analyst Report?

Compare Immunovant (IMVT) vs. Competitors

931 Followers

Comparison Results

IMVT

Immunovant

$29.30

$5.89B

-10.43

102.38%

11 Buy

3 Hold

0 Sell

Strong Buy

Protagonist Therapeutics

$105.98

$6.39B

453.36

126.23%

10 Buy

1 Hold

0 Sell

Strong Buy

Crinetics Pharmaceuticals

$41.00

$3.95B

-7.39

14.62%

8 Buy

0 Hold

0 Sell

Strong Buy

Mirum Pharmaceuticals

$97.95

$6.53B

-1.72

136.87%

10 Buy

0 Hold

0 Sell

Strong Buy

Kymera Therapeutics

$87.71

$7.08B

-29.33

179.75%

16 Buy

0 Hold

0 Sell

Strong Buy

MoonLake Immunotherapeutics

$18.34

$1.24B

-3.40

-57.07%

11 Buy

2 Hold

2 Sell

Moderate Buy

xxxxxxxxxxxxx

IMVT vs MLTX

xxxxxxxxxxxxx

Performance Comparison

IMVT

Immunovant

28.94

14.39

98.90%

PTGX

Protagonist Therapeutics

99.36

54.09

119.48%

CRNX

Crinetics Pharmaceuticals

37.48

4.16

12.48%

MIRM

Mirum Pharmaceuticals

107.16

61.59

135.15%

KYMR

Kymera Therapeutics

86.08

53.91

167.58%

MLTX

MoonLake Immunotherapeutics

17.06

-23.12

-57.54%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >